We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Phase Forward Introduces Phase Forward™ IRT 5.0 Interactive Response Technology Solution
News

Phase Forward Introduces Phase Forward™ IRT 5.0 Interactive Response Technology Solution

Phase Forward Introduces Phase Forward™ IRT 5.0 Interactive Response Technology Solution
News

Phase Forward Introduces Phase Forward™ IRT 5.0 Interactive Response Technology Solution

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Phase Forward Introduces Phase Forward™ IRT 5.0 Interactive Response Technology Solution"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Phase Forward has announced a major new release of its Interactive Response Technology (IRT) solution, Phase Forward™ IRT 5.0. Based on best-in-breed technology gained in the company’s September 2008 acquisition of Clarix, Phase Forward IRT 5.0 gives managers direct control over clinical supply management and helps to provide assurance of supply availability at randomization.

Phase Forward IRT also offers a new integrated drug forecasting module for advanced global clinical trial supply management and a new, enhanced user interface to streamline navigation and consolidate workflow.

“Phase Forward IRT 5.0 is a major step forward in helping customers leverage the power of IRT technology to improve efficiency within clinical trial supply management and planning, a crucial factor in every trial’s success,” said Steve Rosenberg, senior vice president of products and services, Phase Forward. “This release is a key component of our integrated clinical research suite for end-to-end clinical trial management.”

The Phase Forward IRT 5.0 release introduces a new “smart system intelligence” feature that puts clinical supply managers in control, helping them effectively respond to sudden increases in new subjects at any point in the trial. On the basis of user-defined variables, the application will either automatically generate a supply order or notify the supply manager of a potential stock-out, ensuring that subject enrollment is not compromised by lack of study supplies.

The new integrated drug forecasting module gives managers pre-study planning tools to optimize trial supply strategies. During live trials the application links to trial data on demand, enabling managers to compare planning assumptions and forecasts with actual trial data, update supply demand assumptions as needed and modify manufacturing schedules to respond to new projections.

New user interface and dashboard views provide at-a-glance access to critical information, visual status alerts and filtering capabilities to guide users intuitively through tasks, consolidating workflow and helping to ensure that the most pertinent information stays paramount. The release also provides multilingual capabilities, including Japanese, to enable use across the global trial community.

Together, Phase Forward’s IRT and InForm™ GTM electronic data capture (EDC) solutions offer users a tightly integrated solution with a single, unified interface and seamless workflow, providing the total cost of ownership and single point of contact benefits inherent in a single vendor solution.

The Phase Forward IRT 5.0 solution and the optional forecasting module are immediately available.
Advertisement